Scinovex
review Open AccessTop 1% cited

System Xc−/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy

Frontiers in Pharmacology · 2022 · Vol. 13 · pp. 910292–910292
Feng‐Jiao LiHui‐Zhi LongZiwei ZhouHongyu LuoShuo‐Guo XuLichen Gao

Abstract

The activation of ferroptosis is a new effective way to treat drug-resistant solid tumors. Ferroptosis is an iron-mediated form of cell death caused by the accumulation of lipid peroxides. The intracellular imbalance between oxidant and antioxidant due to the abnormal expression of multiple redox active enzymes will promote the produce of reactive oxygen species (ROS). So far, a few pathways and regulators have been discovered to regulate ferroptosis. In particular, the cystine/glutamate antiporter (System X<sub>c</sub> <sup>-</sup>), glutathione peroxidase 4 (GPX4) and glutathione (GSH) (System X<sub>c</sub> <sup>-</sup>/GSH/GPX4 axis) plays a key role in preventing lipid peroxidation-mediated ferroptosis, because of which could be inhibited by blocking System X<sub>c</sub> <sup>-</sup>/GSH/GPX4 axis. This review aims to present the current understanding of the mechanism of ferroptosis based on the System X<sub>c</sub> <sup>-</sup>/GSH/GPX4 axis in the treatment of drug-resistant solid tumors.

Ferroptosis and cancer prognosisCancer, Lipids, and MetabolismInflammatory mediators and NSAID effectsGPX4GlutathioneLipid peroxidationReactive oxygen speciesAntioxidantChemistryOxidative stressBiochemistryCell biologyIntracellular
Citations
369
FWCI
50.62
field-weighted impact
References
296
Percentile
100%
vs. same field & year
Citations per year
Cited by
The diversified role of mitochondria in ferroptosis in cancer
Cell Death and Disease · 2023 · 359 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.